Work

Figure S9 from Targeting BCL2 with Venetoclax Enhances the Efficacy of the KRASG12D Inhibitor MRTX1133 in Pancreatic Cancer

Year: 2026

Type: other

Abstract: Venetoclax enhances the efficacy of MRTX1133 in 2138-K and 1245-K tumors in vivo.

DOI: 10.1158/0008-5472.32705842

Authors: Jeffrey H. Becker, Anastasia E. Metropulos, Christina Spaulding, Alejandra M. Marinelarena, Mario A. Shields, Daniel R. Principe, Thao D. Pham, Hidayatullah G. Munshi

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7165039286

Cites:

Cited by:

Related to: